Self-Guided CBT-I Program Improves Insomnia and Associated Mental Health Symptoms
Adults with insomnia symptoms used the CBT-I program over 18 months and reported significant and sustained improvements.
Category: Cognitive Behavioral Therapy
Cognitive Behavioral Therapy
Latest
Cognitive Behavioral Therapy
Latest
Sleepio Digital Therapeutic Improves Insomnia in Users With Comorbid Anxiety or Stroke
New research reveals that Sleepio reduces anxiety symptoms in individuals with co-existing insomnia and anxiety, while a separate study highlights the treatment's impact on stroke survivors.
Cognitive Behavioral Therapy
Latest
The Insomnia Paradox
Early in my sleep tech career, I figured insomnia was a sleep disorder for the day shift to handle.
Pediatric Insomnia Treatment Is Shifting
How increased awareness of behavioral sleep medicine could be a game-changer for children.
Read More
Partnership Provides Unlimited Sleep Disorder Services to Paramedics
The Coopérative des techniciens ambulanciers de la Montérégie in Canada is offering its members free access to the services of HALEO, a professional virtual sleep clinic.
Read More
Nox Health Closes Acquisition of Somryst
Nox Health has closed the acquisition of Somryst, the only FDA-approved prescription digital therapeutic for adults with chronic insomnia, from Pear Therapeutics.
Read More
Digital Sleep Program Increases Sleep by Over One Hour in Short Sleepers
The digital sleep program, which uses CBT-I-based strategies and text-based coaching, showed meaningful improvements in total sleep time for users in a new study.
Read More
Nox Buys Pear’s Insomnia App for Nearly $4 Million at Auction
Nox Health Group is set to acquire Pear Therapeutics’ Somryst after being selected as the successful bidder at Pear’s bankruptcy auction last week.
Read More
5 Relaxation Techniques for Sleep to Help People with Insomnia
Teach patients these relaxation exercises as part of their insomnia therapy.
Read More
Can Sleep Reactivity Predict Individuals’ Stress Reactions During a Pandemic?
The COVID-19 pandemic offered researchers a rare opportunity to see the effects of a potentially distressing global event on people with sleep reactivity, that is, those who are vulnerable to stress-related sleep disturbances.
Read More
How to Increase Access to Insomnia Therapies with the AASM’s Jennifer L. Martin
Jennifer L. Martin, PhD, speaks about the challenges faced by people with insomnia disorder in accessing CBT-I and pharmaceuticals, as well as posits solutions.
Read More
How Much Does Somryst Reduce Healthcare Costs By Simply Treating Insomnia?
A paper details a health economic analysis of Somryst, including changes in healthcare resource use, associated costs, and insomnia severity.
Read More
ResMed Acquires Mementor. Its Insomnia Solution Builds ResMed’s Digital Sleep Medicine Portfolio in Germany.
ResMed has acquired Leipzig, Germany-based health tech company mementor; the deal was completed on August 1.
Read More
Somryst Lowers Insomnia, Anxiety Symptoms, Depression Severity Through Six Months
Insomnia is linked with anxiety and depression, and a clinical trial evaluates the impact of Somryst on these comorbidities.
Read More
Insomnia Patients in England Will be Offered Treatment with Sleepio App
Hundreds of thousands of insomnia patients will be offered digital cognitive behavioral therapy via the app Sleepio instead of sleeping pills.
Read More
Study: Somryst Users Achieve Significant Reductions in Insomnia Severity through Six Months
Two abstracts presented at World Sleep 2022 provide data on Somryst’s efficacy at six months and on its use in older adults.
Read More
In Older Adults, CBT-I Can Reduce Depression Likelihood by More than 50%
By targeting insomnia and effectively treating it with CBT-I, depression can be effectively prevented by over 50% in community dwelling older adults with insomnia.
Read More
Somryst for Insomnia Gets HCPCS Code
The new HCPCS code for Somryst encompasses “Prescription Digital Behavioral Therapy, FDA Cleared, per Course of Treatment.”
Read More